There are a number of spelling errors and some of the wording is difficult to follow. I appreciate that English may not be the authors' first language but it would be helpful to improve this before publication.
Reviewer #2 (Remarks to the Author):
The authors address a relevant question in the field of fibrosis, and identifies transcription factors of relevance.
The roles of FAK and ERK in fibrosis has been previously established; however, the present study identifies a new link between FAK-ERK and LRG-1 activation with subsequent promotion of angiogenesis.
The methodologies employed in this study are generally sound, with conclusions of some novelty.
However, there are several problematic areas the authors should address, potentially without the need for additional experiments.
(1) There is a lack of clarity on what cell types are over-expressing LRG-1 in Figure 1 .
Overexpression of human LRG1 in endothelial cells has previously been shown to increase cell proliferation (Wang, et al., Nature, 2013) . Is the LRG-1 over-expression presented in this study also found in endothelial cells? If so, why is LRG-1 protein added externally to HUVECs in Figure 2 ? Or is LRG-1 predominantly expressed by the fibroblasts, not endothelial cells?
The logic behind these experimental designs needs to be clarified.
(2) A minor point about this statement:
"mechano-sensitive elements in the cell membrane are activated like integrin-focal adhesion kinase (FAK) complex, stretch-activated ion channels and G-Protein-coupled receptors".
-These are transmembrane receptors or ion channels that are mechano-sensitive. This is a minor issue where rewording would be recommended.
(3) The authors state: "This study providing a new sight that target LRG-1 to uncouple mechanical force from angiogenesis may prove clinically successful across diverse skin fibrosis or other fibroproliferative disorders."
This major conclusions relies on some in vitro studies with HUVECS and the findings presented in Figure 3D . However, the quantification method for Figure 3D Given the strength of the study relies heavily on the functional consequence of LRG-1 in relation to angiogenesis, the quantification methods need to be much more robust and transparent.
(4) There are typographical and grammatical errors throughout the manuscript that the authors should correct, otherwise the manuscript cannot be correctly interpreted by its readers. -To understand the mechanism by which ERK regulates LRG-1 expression, we conducted researches on transcription factors (TFs) regulated by the ERK pathway, meanwhile we used 187 PROMO and JASPAR doing online prediction of TFs binding ability in LRG-1 promoter region.
-The Western blot and immunofluorescence assay both turned out that in siELK1 transfected HDFs, strain-induced LRG-1 expression were mostly hindered.
-Combine PROMO search results (5 binding sites of ELK1 to LRG-1 promoter region) and the ChIP-seq results of difference distribution region (chr19:4541300-4542400), with the certification by ChIP followed QPCR (ChIP-QPCR), we confirmed a binding site (chr19:4541670-4541678) of ELK1 to LRG-1 promoter region ( Fig. 8C-E The manuscript focuses on the molecular mechanisms underlying neovascularization associated with hypertrophic scar formation. A strength of the research is the utilization of in vitro and animal models and the diverse tools used to address this issue. The authors demonstrate a pathway that includes focal adhesion kinase (FAK), ELK and LRG-1 in the response of fibroblasts to mechanical stimulation. The authors also demonstrate that LRG-1 acts on endothelial cells to promote neovascularization. In general, the experiments are well planned and the data are quite extensive. Overall the manuscript is well-written; however, substantial editing is needed to enhance the communication of the data and ideas in the paper.
Several suggestions include:
-Immunoblots should include size markers on the figures or in the figure legends.
-Rationale should be provided in the Methods section for the doses of LRG-1 used in the studies.
-Further explanation should be provided regarding the in vivo mechanical stimulation model.
What was the frequency, magnitude and duration of the stimulation? Also, further discussion regarding the relevance of this model to hypertrophic scar formation would be helpful.
-The X-axis of the graph in Figure 3E should state the units -is this hours?
Responses to Referees' comments:
Response to Reviewer 1:
"Overall, this is a very nice manuscript that, with some modifications, would make an important contribution to the field."
Comment 1
The photomicrographs in Fig inflammation through LPS application. The results turned out that LPS had no effect on LRG-1 expression (Fig. 4C ).
As we noticed the unclear expression in the corresponding section in our manuscript, we have revised the correlated description in the Results section according to the explanation above (under heading "LRG-1 is generated by HDFs due to mechanical loading", paragraph 1). We thank the review again for introducing such a critical and constructive question. Fig. 5G and H as the new Fig. 6 , and increased image size when exporting the images to get a clearer picture to reflect the details of immunohistochemistry.
Comment 6
There are a number of spelling errors and some of the wording is difficult to follow. I appreciate that English may not be the authors' first language but it would be helpful to improve this before publication. There is a lack of clarity on what cell types are over-expressing LRG-1 in Figure 1 .
The logic behind these experimental designs needs to be clarified. Fig. 1. In Fig. 1, we we saw the rising trend of LRG-1 in HS, we did immunohistochemical staining of endothelial cells marker CD31 to testify whether there is an elevation of neovascularization in HS accompanying the increased level of LRG-1 in HS (Fig. 1C) . As the results in Fig. 1 showed that HS has both alleviated LRG-1 expression and neovascularization, we tested the impact of LRG-1 on HUVECs in Fig. 2 to confirm (Fig. 4B, C) . However, mechanical loading significantly increased LRG-1 expression in HDFs in a time-and strength-dependent manner (Fig. 4E, F) , while the expression level of LRG-1 in HUVECs stayed low and unchanged (Fig. 4E, F) . These results indicated that LRG-1 predominantly expressed by the fibroblasts and mechanical force rather than TGF-β1 or inflammation triggered the over-expression of LRG-1.
R: Thank the reviewer for the expert comments. Indeed, we could not identify what cell types are over-expression LRG-1 in

All of the above is our original logic behind these experimental designs, we wonder if
we have explained the doubts of the reviewer, but we are willing to do more explanation if there are any doubts remains.
Comment 2
A minor point about this statement:
-These are transmembrane receptors or ion channels that are mechano-sensitive. This is a minor issue where rewording would be recommended. 
Comment 3
The authors state: "This study providing a new sight that target LRG-1 to uncouple mechanical force from angiogenesis may prove clinically successful across diverse skin fibrosis or other fibroproliferative disorders." This major conclusions relies on some in vitro studies with HUVECS and the findings presented in Figure 3D . However, the quantification method for Figure 3D is not clear. A major weakness of immunohistochemistry is its limited quantitative use. How representative are the images shown? Have non-consecutive tissue slides been used for the quantification? Most importantly, how exactly was the quantification performed?
The authors have left this very vague and this is not acceptable in its current form.
Given the strength of the study relies heavily on the functional consequence of LRG-1 in relation to angiogenesis, the quantification methods need to be much more robust and transparent. (chr19:4541670-4541678 ) of ELK1 to LRG-1 promoter region (Fig. 8C-E) .
These are just some limited examples to demonstrate the need for the authors to check their grammatical errors in order to ensure the concepts they are trying to communicate are presented accurately.
R: Thank the reviewer for pointing this out and the kindly help. We have carefully reviewed the English and grammar and made the corrections. 
Comment 2
Rationale should be provided in the Methods section for the doses of LRG-1 used in the studies.
